🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an prospective study to evaluate the safety and efficacy of naxitam...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2023-06-19
Trial ID
NCT06013618
This research study is testing the combination of two drugs, sargramostim a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-04-16
Trial ID
NCT04703426
Treatments Being Tested
This study seeks to estimate the potential efficacy of the study treatment,...
Status
Unknown
Location
Ascension Providence Rochester Hospital
Start Date
2021-05-19
Trial ID
NCT04713371
RATIONALE: Tyrosine kinase inhibitors may stop the growth of cancer cells b...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-09
Trial ID
NCT00363649
Treatments Being Tested
The effect and safety of intraperitoneal infusion of PD-1 inhibitor is uncl...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT05501340
Treatments Being Tested
This is an open label, single-arm, phase IB treatment study to determine th...
Status
Unknown
Location
Jericho Rabago
Start Date
2021-04-21
Trial ID
NCT03743298
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of SL-701...
Status
Completed
Location
University of Alabama
Start Date
2014-05
Trial ID
NCT02078648
This will be a multi-center, prospective, randomized, single-blinded, place...
Status
Completed
Location
Sarcoma Oncology Research Center, LLC
Start Date
2014-10
Trial ID
NCT02297698
Treatments Being Tested
This trial protocol is designed to evaluate primarily whether the use of sa...
Status
Withdrawn
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-10-23
Trial ID
NCT05482334
Treatments Being Tested
This FTIH study, intends to identify the doses of GSK3358699, which are wel...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-03-13
Trial ID
NCT03426995
Treatments Being Tested